Immune Correlates of COVID-19 Control
COVID-19 caused by SARS CoV2 emerged in China at the end of 2019 and soon become a pandemic. Since the virus is novel, pre-existing CoV2-specific immunity is not expected to exist in humans, although studies have shown presence of CoV2 cross-reactive T cells in unexposed individuals. Lack of effecti...
Main Authors: | Bhawna Poonia, Shyam Kottilil |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.569611/full |
Similar Items
-
Clinical immunity in discharged medical patients with COVID-19
by: Nicola Mumoli, et al.
Published: (2020-10-01) -
Childhood Immunization and COVID-19: An Early Narrative Review
by: Bojana Beric-Stojsic, et al.
Published: (2020-10-01) -
Factors Associated with Intention to Receive Vaccination against COVID-19 in Puerto Rico: An Online Survey of Adults
by: Kyle Melin, et al.
Published: (2021-07-01) -
COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase
by: Scott B. Halstead, et al.
Published: (2020-05-01) -
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
by: Chris R. Triggle, et al.
Published: (2021-02-01)